Navigation Links
Wound Management Technologies, Inc. Announces a Published Case Study
Date:11/20/2008

FORT WORTH, Texas, Nov. 20 /PRNewswire-FirstCall/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (WNDM), announced today a published case demonstrating the efficacy of their advanced wound care collagen product, CellerateRx(R). The case was presented in the November/December 2008 issue of Podiatry Management in the special section, Diabetic Wound Care Management on the Leading Edge: Case Presentations from APWCA, APWCA Case #1: Using Combined Treatment Modalities for Successful Wound Healing. The case was by Jane Fore, MD, a board certified internist and certified wound care specialist, whose practice is totally dedicated to the healing of challenging wounds.

"We are very excited about the unsolicited case published in this month's edition of Podiatry Management," states Cathy Bradshaw, President of Wound Care Innovations. "Diabetic foot wounds with infections can be complicated and can require multiple approaches to treatment. This case demonstrates the biocompatibility of CellerateRx(R) in supporting the successful take of living skin equivalents and the delivery of antimicrobials when used in combinational therapies. The article further reports CellerateRx's(R) effectiveness in treating tunneling wounds, and is easy to use. Packing and unpacking these tunneling wounds can be very painful for the patient. CellerateRx(R) is biodegradable and does not need to be removed from the wound. We are delighted to be able to provide to the market a unique, patented advanced wound care collagen product to assist in the management of these difficult wounds."

Diabetic wounds are problematic for patients and a drain on the healthcare industry. In the United States, it is estimated that 15-20% of diabetics will develop a foot ulcer in their lifetime and that 14-24% of these ulcers will result in amputations. Every 30 seconds a leg is lost to diabetes somewhere in the world.


'/>"/>
SOURCE Wound Management Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
2. Surgical and Trauma Wound Care Market to Tie Up $7 Billion in Sales by 2011
3. Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008
4. MUSC Spin-Off Company to Test Regenerative Wound Healing Gel
5. Arobella Medical, LLC Launches Qoustic Wound Therapy System(TM)
6. QED International Associates Announces Changes to the HealthShares(TM) Dermatology and Wound Care Index
7. Kingfisher Healthcare Receives European CE Mark for Next Generation Wound Healing Device
8. Derma Sciences Announces Clinical Poster on Use of MEDIHONEY(TM) Wound & Burn Dressings Wins First Place Award at APWCA
9. Cleveland Clinic and Rutgers to Lead Newly Formed Institute for War Wounded
10. Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn Dressings
11. CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... August 27, 2015 , ... Inc. Magazine released its annual ... Solutions as number 1,361 in growth for the three years through 2014. Being named ... fastest-growing privately held organizations in the country. , “We are thrilled to make ...
(Date:8/27/2015)... ... August 27, 2015 , ... Proove Biosciences, ... data on the relationship of genetics and hypertension at the International Academy ... in Vancouver, British Columbia, Canada. The event, which boasts an extensive overview of ...
(Date:8/26/2015)... , Aug. 26, 2015  Roka Bioscience, Inc. (NASDAQ: ... providing advanced testing solutions for the detection of foodborne ... present at the Sidoti & Company Emerging Growth Conference ... be held at the New York Marriott Marquis. ... be available through the investor relations section of Roka ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic ... it has received a $1.5M Phase II SBIR ... to further develop its therapeutic agent to reduce ... need in end stage renal disease (ESRD) patients ... National Institute of Diabetes and Digestive and Kidney ...
Breaking Biology Technology:iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3
... Calif., May 18, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: ... Officer of BioMarin, will present a company update at the ... 25, 2011 at 9:30 a.m. GMT.   Interested ... call via the investor section of the BioMarin website, ...
... Northwest Biotherapeutics (OTC Bulletin Board: NWBO ) ... production of DCVax®-L for brain cancer, for clinical trials ... largest applied research foundation in Europe, with a staff ... others dedicated to practical applications and commercialization of research ...
... presented today show that RAPAFLO(R) (silodosin) significantly reduced ... pain syndrome (CP/CPPS).  In the study presented at ... RAPAFLO(R) also significantly improved urinary symptoms as well ... pelvic pain syndrome (CP/CPPS) is a common condition ...
Cached Biology Technology:BioMarin to Present at the UBS Global Specialty Pharmaceuticals Conference 2Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe 2Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe 3Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe 4Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 2Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 3Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 4Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 5Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 6
(Date:7/31/2015)... , 31 de julio de 2015 ... (ICG-10,  www.icg-10.org ) del 22 al 25 de octubre ... La conferencia celebra su décimo aniversario este ... convertido en una de las reuniones anuales más influyentes ... es una de las conferencias científicas más dinámicas, entusiastas ...
(Date:7/31/2015)... de 2015 La 10 th International Conference ... de BGI del 22 al 25 de octubre de 2015 en ... año, la conferencia celebra su décimo aniversario. Desde su inauguración ... de las reuniones anuales más influyentes del mundo en el ... dinámicas, entusiastas y mejores a nivel científico. ...
(Date:7/31/2015)... -- The 10 th International Conference on Genomics (ICG-10, ... 2015, in Shenzhen , China ... th anniversary this year. Since its inauguration in 2006, ... meetings in the ,omics, fields, and is one of the ... ICG-10 focuses on recent breakthroughs and advances in ,omics, research ...
Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3The 10th International Conference on Genomics (ICG-10) to Open in October 2
... press release is available in German . ... discovered an unusual regulation of enzymes that catalyze chain ... In the horseradish leaf beetle Phaedon cochleariae ... completely different substances depending on whether it is regulated ...
... OH, February 28, 2013 -- Although the long-term consequences ... have reduced physical education classes to devote more time ... However, there is new evidence that leaving out ... test scores. A new study scheduled for publication ...
... the March issue of GSA Today , seven scientists ... of Leicester, propose a realignment of the terms "geochronology" and ... units of the Geological Time Scale should have a single ... system, which retains both parallel sets of units, with an ...
Cached Biology News:Metal ions regulate terpenoid metabolism in insects 2Metal ions regulate terpenoid metabolism in insects 3Reading, writing, arithmetic, and aerobics -- Evaluating the new 'R' in academic performance 2
Mouse monoclonal [050-04] to C2 ( Abpromise for all tested applications). entrezGeneID: 717 SwissProtID: P06681...
Rabbit polyclonal to Bag5 ( Abpromise for all tested applications). entrezGeneID: 9529 SwissProtID: Q9UL15...
Rabbit polyclonal to Tryptophanyl tRNA synthetase ( Abpromise for all tested applications). Antigen: Recombinant full length protein (Human): Tryptophanyl tRNA synthetase Entrez Gene ID: 745...
WTAP Antibody...
Biology Products: